Search results for "Mycose"

showing 10 items of 351 documents

Characterization of the Carbapenem-Hydrolyzing Oxacillinase Oxa-58 in an Acinetobacter Genospecies 3 Clinical Isolate

2008

ABSTRACT Based on imipenem resistance in an Acinetobacter genospecies 3 clinical isolate, we were able to identify, for the first time in this genomic species, a plasmid-encoded bla OXA-58 gene that was 100% homologous to the same gene in Acinetobacter baumannii .

ImipenemCarbapenemMolecular Sequence DataMicrobial Sensitivity TestsBiologybeta-LactamasesMicrobiologyPlasmidBacterial ProteinsMechanisms of Resistancepolycyclic compoundsmedicineHumansPharmacology (medical)Antibacterial agentPharmacologyAcinetobacterBase SequenceSequence Analysis DNAbiochemical phenomena metabolism and nutritionAcinetobacterbacterial infections and mycosesbiology.organism_classificationAnti-Bacterial AgentsAcinetobacter baumanniiImipenemInfectious DiseasesCarbapenemsNeisseriaceaeBacteriaAcinetobacter InfectionsPlasmidsmedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

ESBL-producing Klebsiella pneumoniae in a University hospital: Molecular features, diffusion of epidemic clones and evaluation of cross-transmission.

2021

The worldwide spread of Klebsiella pneumoniae producing extended-spectrum β-lactamase (ESBL-Kp) is a significant threat. Specifically, various pandemic clones of ESBL-Kp are involved in hospital outbreaks and caused serious infections. In that context, we assessed the phenotypic and molecular features of a collection of ESBL-Kp isolates in a French university hospital and evaluated the occurrence of potential cross-transmissions. Over a 2-year period (2017–2018), 204 non-duplicate isolates of ESBL-Kp were isolated from clinical (n = 118, 57.8%) or screening (n = 86, 42.2%) sample cultures. These isolates were predominantly resistant to cotrimoxazole (88.8%) and ofloxacin (82.8%) but remaine…

ImipenemNosocomial InfectionsEpidemiologyKlebsiella pneumoniaePathology and Laboratory MedicineKlebsiella PneumoniaeHospitals UniversityMedical ConditionsKlebsiellaDrug Resistance Multiple BacterialPandemicMedicine and Health Sciences0303 health sciencesMultidisciplinarybiologyQRHospitalsBacterial PathogensAnti-Bacterial AgentsBacterial Typing Techniques3. Good healthIntensive Care UnitsInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyMedical MicrobiologyAmikacinGenetic EpidemiologyMedicinePathogensResearch Articlemedicine.drugScienceContext (language use)Research and Analysis MethodsMicrobiologybeta-LactamasesMicrobiology03 medical and health sciencesmedicineHumansGenetic variabilityMolecular Biology TechniquesMolecular BiologyMicrobial PathogensRetrospective Studies030304 developmental biologyBacteria030306 microbiologyOrganismsBiology and Life SciencesOutbreakbiochemical phenomena metabolism and nutritionbiology.organism_classificationbacterial infections and mycosesKlebsiella InfectionsHealth CareHealth Care FacilitiesMultilocus sequence typing[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyCloningPLoS ONE
researchProduct

Probable disseminated Mycobacterium abscessus subspecies bolletii infection in a patient with idiopathic CD4+ T lymphocytopenia: a case report.

2012

Abstract Introduction Rapidly growing mycobacteria are opportunistic pathogens in patients with underlying risk factors. Mycobacterium abscessus subsp. bolletii is a newly recognized member of rapidly growing mycobacteria, isolated from respiratory tract and cutaneous infections. Case presentation We describe a case of chronic disseminated infection caused by M. abscessus subsp. bolletii in a 38-year-old Sri Lankan man with idiopathic CD4+ T lymphocytopenia. Idiopathic CD4+ T lymphocytopenia is a rare cause of immunodysfunction that, similar to human immunodeficiency virus infection, causes a depletion of CD4+ T lymphocytes. M. abscessus subsp. bolletii infection was diagnosed by culture is…

ImipenemSettore MED/07 - Microbiologia E Microbiologia ClinicaDisseminated infectionlcsh:MedicineCase ReportMycobacterium abscessusMicrobiologyMycobacterium abscessus subsp. bolletii rapidly growing mycobacteriaClarithromycinMycobacterium bolletiiClarithromycinmedicineCefoxitinMedicine(all)biologybusiness.industryPatient affectedlcsh:RMycobacterium bolletiiGeneral MedicineMycobacterium bolletii; idiopathic CD4+ T lymphocytopeniabiology.organism_classificationbacterial infections and mycosesCD4+ T lymphocytopeniaImmunologyidiopathic CD4+ T lymphocytopeniaSputumbacteriaCD4+ T-Lymphocytopeniamedicine.symptom<it>Mycobacterium abscessus</it> subsp. <it>bolletii</it> rapidly growing mycobacteriabusinessmedicine.drug
researchProduct

&lt;i&gt;Aeromonas hydrophila&lt;/i&gt; subsp. &lt;i&gt;dhakensis&lt;/i&gt; Isolated from Feces, Water and Fish in Mediterranean Spain

2012

Eight Aeromonas hydrophila-like arabinose-negative isolates from diverse sources (i.e., river freshwater, cooling-system water pond, diseased wild European eels, and human stools) sampled in Valencia (Spain) during 2004–2005, were characterized by 16S rRNA gene sequencing and extensive biochemical testing along with reference strains of most Aeromonas species. These isolates and all reference strains of A. hydrophila subsp. dhakensis and A. aquariorum showed a 16S rRNA sequence similarity of 99.8–100%, and they all shared an identical phenotype. This matched exactly with that of A. hydrophila subsp. dhakensis since all strains displayed positive responses to the Voges-Prokauer test and to t…

ImipenembiologySoil ScienceVirulencePlant ScienceGeneral Medicinebiochemical phenomena metabolism and nutritionRibosomal RNAbacterial infections and mycoses16S ribosomal RNAbiology.organism_classificationMicrobiologyAeromonasTicarcillinmedicinebacteriaCefoxitinEcology Evolution Behavior and SystematicsFecesmedicine.drugMicrobes and Environments
researchProduct

Complex Cellular Responses of Helicobacter pylori-Colonized Gastric Adenocarcinoma Cells ▿

2011

ABSTRACT Helicobacter pylori is an important class I carcinogen that persistently infects the human gastric mucosa to induce gastritis, gastric ulceration, and gastric cancer. H. pylori pathogenesis strongly depends on pathogenic factors, such as VacA (vacuolating cytotoxin A) or a specialized type IV secretion system (T4SS), which injects the oncoprotein CagA (cytotoxin-associated gene A product) into the host cell. Since access to primary gastric epithelial cells is limited, many studies on the complex cellular and molecular mechanisms of H. pylori were performed in immortalized epithelial cells originating from individual human adenocarcinomas. The aim of our study was a comparative anal…

ImmunologyImmunoblottingAdenocarcinomaMicrobiologyHelicobacter InfectionsStomach NeoplasmsCell Line TumormedicineGastric mucosaCell AdhesionCagAHumansImmunoprecipitationSecretionInterleukin 8Cell adhesionAuthor CorrectionbiologyHelicobacter pyloriReverse Transcriptase Polymerase Chain ReactionInterleukin-8Bacterial InfectionsHelicobacter pylorimedicine.diseasebiology.organism_classificationbacterial infections and mycosesdigestive system diseasesInfectious Diseasesmedicine.anatomical_structureCell cultureBacterial TranslocationImmunologyHost-Pathogen InteractionsCancer researchAdenocarcinomaParasitology
researchProduct

Functional C1-inhibitor diagnostics in hereditary angioedema: Assay evaluation and recommendations

2008

Hereditary angioedema (HAE) is an autosomal dominant disease characterized by recurrent episodes of potentially life-threatening angioedema. The most widespread underlying genetic deficiency is a heterozygous deficiency of the serine protease inhibitor Cl esterase inhibitor (C1-Inh). In addition to low C4 levels, the most important laboratory parameter for correct diagnosis of HAE or angioedema due to acquired C1-Inh deficiency is reduced C1-Inh function (fC1-Inh). No direct recommendations about the assays for fC1-Inh or sample handling conditions are available, although this would prove especially useful when a laboratory first starts to offer assays on fC1-Inh for HAE diagnosis. In the p…

ImmunologyMESH: Complement C1 Inactivator ProteinsEnzyme-Linked Immunosorbent AssayMESH: Blood Specimen CollectionComplement C1 Inactivator Proteins[SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunityC1-inhibitor03 medical and health sciences0302 clinical medicinemedicineHumansImmunology and AllergyMESH: Angioedemaheterocyclic compoundsAngioedema030304 developmental biologySample handlingBlood Specimen Collection0303 health sciencesMESH: HumansAngioedemabiologybusiness.industryTemperatureAutosomal dominant traitMESH: Enzyme-Linked Immunosorbent Assaybiochemical phenomena metabolism and nutritionrespiratory system[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismSerum samplesmedicine.diseasebacterial infections and mycosesMESH: Temperature3. Good healthC1 esteraserespiratory tract diseases030228 respiratory systemImmunologyHereditary angioedemabiology.proteinmedicine.symptombusinessJournal of Immunological Methods
researchProduct

Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate

2009

AbstractLeukocytes migrate from the blood into areas of inflammation by interacting with various adhesion molecules on endothelial cells. Vascular adhesion protein-1 (VAP-1) is a glycoprotein expressed on inflamed endothelium where it plays a dual role: it is both an enzyme that oxidizes primary amines and an adhesin that is involved in leukocyte trafficking to sites of inflammation. Although VAP-1 was identified more than 15 years ago, the counterreceptor(s) for VAP-1 on leukocytes has remained unknown. Here we have identified Siglec-10 as a leukocyte ligand for VAP-1 using phage display screenings. The binding between Siglec-10 and VAP-1 was verified by different adhesion assays, and this…

ImmunologyReceptors Cell SurfaceInflammationCHO CellsPlasma protein bindingBiologyLigandsBiochemistryMice03 medical and health sciencesCricetulus0302 clinical medicinePeptide LibraryVascular BiologyCricetinaeLectinsLeukocyte TraffickingCell AdhesionmedicineAnimalsHumansEndotheliumLymphocytesProtein Structure QuaternaryCell adhesion030304 developmental biologyMice Knockout0303 health sciencesCell adhesion moleculeSoluble cell adhesion moleculesSIGLECCell BiologyHematologyAdhesionrespiratory systembacterial infections and mycosesRecombinant Proteinsrespiratory tract diseasesChemotaxis LeukocyteBiochemistry030220 oncology & carcinogenesisAmine Oxidase (Copper-Containing)medicine.symptomCell Adhesion MoleculesProtein BindingBlood
researchProduct

Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida al…

2008

Candida albicans is the major cause of systemic fungal infections in immunocompromised patients. We investigated the susceptibility of mice deficient in complement factor B and C2 (Bf/C2-/-), C1q (C1qa-/-), and mannan-binding lectin (MBL)-A (MBL-A) and MBL-C (MBL-A/C-/-) to systemic infection with C. albicans. Animals were infected i.p. with 10(8)C. albicans blastoconidia and monitored for mortality. Bf/C2-/- mice showed high mortality (over 90%) within the study period of 3 weeks. In contrast, mortality in C1qa-/- mice was below 15% whereas that of MBL-A/C-/- mice was 40% (P0.001). Intravenous infection of mice with 8x10(5) blastoconidia resulted in the same trend with Bf/C2-/- mice being …

Immunologychemical and pharmacologic phenomenaOpportunistic InfectionsMannose-Binding LectinBlastoconidiumComplement factor BMicrobiologyMicePhagocytosisSpecies SpecificityCandida albicansAnimalsGenetic Predisposition to DiseaseCandida albicansDouble knockoutComplement ActivationMolecular BiologyMannan-binding lectinMice KnockoutbiologyCandidiasisLectinComplement Pathway Mannose-Binding LectinComplement C2bacterial infections and mycosesbiology.organism_classificationCorpus albicansKnockout mousebiology.proteinComplement Factor BMolecular Immunology
researchProduct

European expert opinion on the management of invasive candidiasis in adults

2011

Item does not contain fulltext This report discusses the present status of antifungal therapy and treatment options for candidaemia, considered by experts in the field in Europe. A conference of 26 experts from 13 European countries was held to discuss strategies for the treatment and prevention of invasive candidiasis, with the aim of providing a review on optimal management strategies. Published and unpublished comparative trials on antifungal therapy were analysed and discussed. Commonly asked questions about the management of candidaemia were selected, and possible responses to these questions were discussed. Panellists were then asked to respond to each question by using a touchpad ans…

Invasive mycoses and compromised host Translational research [N4i 2]AdultMicrobiology (medical)medicine.medical_specialtyAntifungal Agentsmedicine.medical_treatmentPlacebo-controlled studyMEDLINEInvasive mycoses and compromised host Infection and autoimmunity [N4i 2]MicrobiologyMedicineHumanscandidaemiaCandidiasis InvasiveguidelinesIntensive care medicineWatchful Waitingtherapybusiness.industryTreatment optionsPathogenesis and modulation of inflammation Infection and autoimmunity [N4i 1]General MedicineInvasive candidiasisComparative trialAntibiotic Prophylaxismedicine.diseaseOptimal managementEuropeIntensive Care UnitsInfectious DiseasesconsensusExpert opinioncandidabusinessWatchful waitingClinical Microbiology and Infection
researchProduct

Utilization of hemin and hemoglobin by Vibrio vulnificus biotype 2

1996

The eel pathogen Vibrio vulnificus biotype 2 is able to use hemoglobin (Hb) and hemin (Hm) to reverse iron limitation. In this stud, the adjuvant effect of both compounds on eel pathogenicity has been evaluated and confirmed. Further, we have studied the heme-iron acquisition mechanism displayed by this bacterium. Whole cells were capable of binding Hb and Hm, independently of (i) iron levels in growth medium and (ii) the presence of polysaccharide capsules on bacterial surface. The Hb- and Hm-binding capacity was retained by the outer membrane protein (OMP) fraction and was abolished after proteolytic digestion of OMP samples. Western blotting (immunoblotting) of denatured OMPs revealed th…

IronVibrio vulnificusApplied Microbiology and BiotechnologyMicrobiologyHemoglobinschemistry.chemical_compoundVibrionaceaeAnimalsHemeVibrioEelsVirulenceEcologybiologyProteolytic enzymesbacterial infections and mycosesbiology.organism_classificationVibriochemistryBiochemistryHeminbacteriaHemoglobinCarrier ProteinsBacterial outer membraneBacterial Outer Membrane ProteinsResearch ArticleFood ScienceBiotechnologyHeminApplied and Environmental Microbiology
researchProduct